SRAM
Spouting Rock Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $246K | Sell |
3,445
-5,774
| -63% | -$412K | 0.09% | 101 |
|
|
2023
Q3 | $552K | Hold |
9,219
| – | – | 0.18% | 83 |
|
|
2023
Q2 | $665K | Hold |
9,219
| – | – | 0.24% | 83 |
|
|
2023
Q1 | $678K | Buy |
+9,219
| New | +$678K | 0.24% | 80 |
|
|
2022
Q4 | – | Sell |
-2,646
| Closed | -$228K | – | 160 |
|
|
2022
Q3 | $228K | Buy |
+2,646
| New | +$228K | 0.18% | 118 |
|
|
2021
Q2 | – | Sell |
-1,321
| Closed | -$201K | – | 224 |
|
|
2021
Q1 | $201K | Buy |
+1,321
| New | +$201K | 0.06% | 201 |
|
|
2020
Q4 | – | Sell |
-16,887
| Closed | -$1.61M | – | 186 |
|
|
2020
Q3 | $1.61M | Buy |
16,887
+2,382
| +16% | +$227K | 0.77% | 34 |
|
|
2020
Q2 | $1.62M | Buy |
14,505
+3,844
| +36% | +$430K | 0.77% | 32 |
|
|
2020
Q1 | $775K | Sell |
10,661
-4,303
| -29% | -$313K | 0.54% | 52 |
|
|
2019
Q4 | $1.56M | Buy |
+14,964
| New | +$1.56M | 0.4% | 71 |
|